Trial Profile
A Long-Term Follow-up Study of Chondrogen - Adult Human Stem Cells Delivered by Intra-articular Injection Following Meniscectomy in Subjects 18-60 Years [EXTENSION OF 700244911]
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Mesenchymal stem cell therapy (Primary)
- Indications Knee injuries
- Focus Adverse reactions
- Sponsors Osiris Therapeutics
- 03 Dec 2014 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov record.
- 28 May 2014 New trial record